Financials
Financial year 2025
Revenue
€ 14.9 million
▲ 72% vs 2024
Profit
Caution€ -54,903
▼ 283% vs 2024
Debts
High€ 49.7 million
▲ 24% vs 2024
Telix Pharmaceuticals (Belgium) from Seneffe, company number BE0695832765, closed financial year 2025 with a result of € -54,903 after tax. For that financial year Telix Pharmaceuticals (Belgium) recorded revenue of € 14.9 million and equity of € 515,466. Compared with financial year 2024, the result moved from € 30,074 to € -54,903. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.
What happened at Telix Pharmaceuticals (Belgium)?
What happened at Telix Pharmaceuticals (Belgium) in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Ortiz Raphael stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 54,903 (▼ 283% vs 2024). Source: NBB ↗
- Caroline Defraiteur became a director. NBB
- Ortiz Raphael became a director. NBB
- New establishment in Seneffe. KBO
- Start of the company according to the CBE. KBO
In short
From € 64,209 profit in 2021 to € 54,903 loss in 2025.
Paid € 339,658 in corporate taxes since 2021.
Best year ever: 2021, with € 64,209 profit.
On average € 120,000 of value added per employee in 2023.
A new publication or filing at Telix Pharmaceuticals (Belgium)? We notify you, reason included.
Follow Telix Pharmaceuticals (Belgium)Need more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Telix Pharmaceuticals (Belgium) is Caroline Defraiteur. The shares are held by Telix International Pty Ltd Autre (100%).
Directors
According to the 2025 annual accounts
Caroline Defraiteur
Director
since 2025
Ortiz Raphael
Director
since 2023 · until 2029
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue Jules Bordet 55
7180 Seneffe
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0695.832.765
- VAT number
- BE 0695.832.765
- Registered office
- Rue Jules Bordet 55, 7180 Seneffe
- Names & denominations
- Telix Pharmaceuticals (Belgium)
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 May 2018
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Vervaardiging van overige farmaceutische producten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Vervaardiging van geneesmiddelen